Dr. Moskowitz will work with the study team to tailor the positive affect intervention for delivery as part of the Phase I work. She will participate in co-investigator meetings and conference calls to assist with trial implementation, interpretation of the results, and manuscript preparation.
|Effective start/end date||9/30/19 → 7/31/21|
- University of Miami (SPC-001373//FR01DA049843-02)
- National Institute on Drug Abuse (SPC-001373//FR01DA049843-02)